Diagnostic Electrocardiograph (ECG) Market By Offering (Systems (Holter ECG, Stress/ Exercise Testing ECG, Resting ECG, Insertable Cardiac Monitor (ICM), Mobile Cardiac Telemetry (MCT), Event Recorder, & Others) Parts & Accessories, Software, and Services); By Lead Type (12 Lead, 5 Lead, 3 Lead, 6 Lead, and Others); By End Users (Hospitals & Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others); By Region (North America (U.S., Canada, Mexico, & Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden & Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), & Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore & Rest of Southeast Asia), & Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, & Rest of Middle East & Africa) Latin America (Brazil, Argentina, & Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Diagnostic electrocardiograph (ECG) is defined as a type of test that is generally used for measuring the heart’s rhythm and electrical activity. ECG technique records electrical activity of the heartbeat over a span of time. Its non-invasive nature is making it popular and accelerating the growth of diagnostic electrocardiograph (ECG) market. Every heartbeat generates an electrical impulse that is captured by ECG devices through electrodes rested on the body of a patient. ECG devices can measure any damage to the heart, speed of heartbeat, normalcy of heartbeat, effects of drugs or devices used to control the heart, and the size as well as position of heart chambers.
In September 2021, a joint collaboration between biopharmaceutical company AstraZeneca India and Bengaluru-based startup Tricog, unveiled a programme called ‘Project Heart Beat’. The purpose of this program is to ensure early and accurate diagnosis of heart attacks so that the mortality rates caused by heart attacks can be reduced. This project is expected to address the unmet need for early diagnosis and timely intervention for patients that are prome to heart attack. The diagnosis is supposed to be done by enabling cloud-based artificial intelligence (AI) supported interpretation of ECGs. This would help patients to find the nearest cath Labs or fibrinolysis centers, saving their travel time. This can help with early as well as accurate diagnosis, along with timely treatment.
In the global diagnostic electrocardiograph (ECG) market, the major drivers contributing to the market growth are non-invasive nature of ECG technology, improving healthcare infrastructure, and supportive reimbursement policies. Increasing incidences of lifestyle associated diseases such as hypertensive heart disease, ischemic heart disease (IHD), peripheral artery diseases, and stroke are also fueling the market growth.
The factors including increase in geriatric population, technical developments in the wireless monitoring, rise in government funding, technological advancements in medical sector, increased investments into research & development (R&D), along with the increasing role of wireless monitoring & wearable devices in for measuring the activities of heart are anticipated to proliferate the growth of global diagnostic electrocardiograph (ECG) market over the forecast period. According to the 2017 Apple Heart Study, Apple Watch was cited to detect various types of arrhythmic heart beat irregularities and atrial fibrillation (AFib). Currently, Apple Watch offers potential AFib detection and notifications as one of its key health features. With the device receiving its Series 4 update, Apple Watch also features ECG sensor functionality. However, unfavorable reimbursement policies is a big restraint in the growth of global diagnostic electrocardiograph (ECG) market.
Being a lower respiratory tract infection, China-originated coronavirus severely affects the cardiovascular system, leading to abnormal ECG findings. Associated with a variety of ECG abnormalities, COVID-19 is a potentially critical illness that can cause at least one abnormality in up to 90% of critically ill patients. The ECG abnormalities caused by coronavirus include coronary spasm, cytokine storm, direct endothelial injury, electrolyte abnormalities, hypoxic injury, microthrombi, myocardial injury, and plaque rupture. Coronavirus can also lead to complications that can worsen prognoses for patients with underlying heart conditions, especially those suffering from any kind of cardiovascular disease. Hence, exploration of methods of using ECG devices to evaluate heart condition and detect coronavirus infection with greater accuracy can open new opportunities for the growth of global diagnostic electrocardiograph (ECG) market.
In terms of revenue, diagnostic electrocardiograph (ECG) market was valued at US$ 7953.10 Mn in 2020 growing at a CAGR of 6.9% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Diagnostic Electrocardiograph (ECG) Market Revenue & Forecast, (US$ Million), 2021 – 2029
Offering Outlook:
In the context of offering, the global diagnostic electrocardiograph (ECG) market has been primarily segmented into systems, parts & accessories, software, and services. The system sub-segment has been further classified into Holter ECG, stress/ exercise testing ECG, resting ECG, insertable cardiac monitor (ICM), mobile cardiac telemetry (MCT), event recorder, and others.
Among these categories, resting ECG accounted for the largest market share in 2020. The resting ECG detects certain heart conditions such as cardiac arrhythmias, hypertrophy of heart, ischemia, and myocardial infarction, etc. The high usage of resting ECG devices in hospitals contributed to the market growth of this category. Other factors contributing to the market growth include increasing stress levels, especially among the youngsters and growing consistency of hospital visits by patients.In September 2021, a US-based healthcare innovator, Cardiac Insight Inc. signed a distribution agreement with Lovell Government Services (LGS), a Service-Disabled Veteran-Owned Small Business (SDVOSB), enabling it to expand their consumer base and reach of the products. Cardiac Insight Inc. is engaged in development of wearable cardiac sensors and resting ECG equipment, along with proprietary software that can automatically analyze ECG testing so that cardiac arrhythmias can be detected as well as diagnosed earlier and faster.
In the systems market, insertable cardiac monitor (ICM) sub-segment is expected to become the fastest growing market during the forecast period. As the role of technology is increasing in medical sector, the advanced ICM devices are more sensitive and ensure 97.9% accuracy. Today there are apps integrated with ICM devices. These apps can ensure remote connectivity for doctors and help them to receive precise, actionable data faster than obsolete ICM devices. ICM devices, which are small electrophysiology (EP) devices, are used for long-term monitoring of a patient's heart electrical activity so that arrhythmias can be detected. ICM can be inserted under the patient's skin during meeting with doctor and they can record cardiac data continuously for up to 4.5 years. This eliminates the need for bulky external Holter monitor which doctors can use only when they attach wire leads to the patient. This factor is increasing the popularity of ICMs, and thereby enhancing the growth of global diagnostic electrocardiograph (ECG) market.
Lead Type Outlook:
By lead type of global diagnostic electrocardiograph (ECG) market, the market has been segmented into 3 lead, 5 lead, 6 lead, 12 lead, and others. 12 lead category accounted for the largest market share in diagnostic electrocardiograph (ECG) market in 2020.
During the forecast period, 3 lead category is estimated to become the fastest growing market segment due to their usability with various types of cardiac diagnostic tests and telemetry monitoring. They are also used in medical procedures such as emergencies and heart disease management.
End Users Outlook:
On the basis of end users, the global diagnostic electrocardiograph (ECG) market has been segmented into hospitals & clinics, ambulatory surgical centers, cardiac centers, and others.
Hospitals & clinics category was the largest market segment in 2020 due to the growing burden of cardiovascular diseases. The cardiovascular diseases is increasing the need for quality cardiology care and thus, the number of patient visits to physician offices for the diagnosis of cardiovascular diseases is also increasing. Facilities provided by hospitals to patients such as isolation wards, screening tests, and other health care facilities, along with healthcare infrastructure are boosting market growth.
Region Outlook:
North America accounted for a significant share in the global diagnostic electrocardiograph (ECG) market in 2020. However, during the forecast period, the Asia Pacific region is expected to become the fastest growing regional market due to factors like the growing incidence of chronic diseases, growing geriatric population, increasing demand for advanced technologies, healthcare reforms for infrastructural development, rising healthcare spending, and less stringent regulations in the countries of Asia Pacific region.
In countries like China, India, Japan, and other Asian countries, where the role of technology is rapidly increasing in the medical sector, are expected to extend profitable opportunities for the growth of the global diagnostic electrocardiograph (ECG) market in the coming years. Cardiovascular diseases is among the leading causes of death in India. Hence, the demand for ECG devices is very strong in India and the market can grow in the coming future as the role of technology is also growing in the medical sector. In January 2018, data from the National Center for Biotechnology Information (NCBI) of Japan revealed that every year in Japan, 422 people out of every 100,000 people suffered from stroke. In September 2021, Japanese government sanctioned Guyanese $ 205.8 million grant in fight against COVID-19. This financial aid is meant to be primarily used for the purchase of ultrasound machines; sterilizers, and ECG machines.
Competitive Landscape
The report provides both, qualitative as well as quantitative research of global diagnostic electrocardiograph (ECG) market. It also provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as affiliations, collaborations, mergers & acquisitions (M&A), and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the diagnostic electrocardiograph (ECG) market are BPL Medical Technologies, EDAN Instruments Inc., FUKUDA DENSHI, General Electric Company, Hill-Rom Holdings Inc., Koninklijke Philips N.V., Medtronic, NIHON KOHDEN CORPORATION, Norav Medical, OSI Systems Inc., SCHILLER, and Shenzhen Mindray Bio-Medical Electronics Co. Ltd amongst other market participants.
Global Diagnostic Electrocardiograph (ECG) Market:
By Offering
- Systems
- Holter ECG
- Stress/ Exercise Testing ECG
- Resting ECG
- Insertable Cardiac Monitor (ICM)
- Mobile Cardiac Telemetry (MCT)
- Event Recorder
- Others
- Parts & Accessories
- Software
- Services
By Lead Type
- 12 Lead
- 5 Lead
- 3 Lead
- 6 Lead
- Others
By End Users
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
By Region
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Diagnostic Electrocardiograph (ECG)
Market
6. Market Synopsis:
Diagnostic Electrocardiograph (ECG) Market
7. Diagnostic Electrocardiograph (ECG) Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Diagnostic Electrocardiograph (ECG) Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Diagnostic Electrocardiograph (ECG) Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Diagnostic Electrocardiograph (ECG) Market
8. Global Diagnostic Electrocardiograph (ECG) Market Analysis
and Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global
Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn)
8.2. Global
Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and Forecasts, By
Offering
8.2.1. Systems
(Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation
(2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Holter ECG, Stress/ Exercise
Testing ECG, Resting ECG, Insertable Cardiac Monitor (ICM), Mobile Cardiac
Telemetry (MCT), Event Recorder, Others)
8.2.1.1. Holter ECG
8.2.1.2. Stress/ Exercise Testing ECG
8.2.1.3. Resting ECG
8.2.1.4. Insertable Cardiac Monitor (ICM)
8.2.1.5. Mobile Cardiac Telemetry (MCT)
8.2.1.6. Event Recorder
8.2.1.7. Others
8.2.2. Parts
and Accessories
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2020
8.2.2.3. Market Forecast, 2021 - 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2020
8.2.2.5.1.2. Market
Forecast, 2021 - 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2020
8.2.2.5.2.2. Market
Forecast, 2021 - 2029
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2020
8.2.2.5.3.2. Market
Forecast, 2021 - 2029
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2020
8.2.2.5.4.2. Market
Forecast, 2021 - 2029
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2020
8.2.2.5.5.2. Market
Forecast, 2021 - 2029
8.2.3. Software
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2020
8.2.3.3. Market Forecast, 2021 - 2029
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2020
8.2.3.5.1.2. Market
Forecast, 2021 - 2029
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2020
8.2.3.5.2.2. Market
Forecast, 2021 - 2029
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2020
8.2.3.5.3.2. Market
Forecast, 2021 - 2029
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2020
8.2.3.5.4.2. Market
Forecast, 2021 - 2029
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2020
8.2.3.5.5.2. Market
Forecast, 2021 - 2029
8.2.4. Services
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 - 2020
8.2.4.3. Market Forecast, 2021 - 2029
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2015 - 2020
8.2.4.5.1.2. Market
Forecast, 2021 - 2029
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2020
8.2.4.5.2.2. Market
Forecast, 2021 - 2029
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2020
8.2.4.5.3.2. Market
Forecast, 2021 - 2029
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2020
8.2.4.5.4.2. Market
Forecast, 2021 - 2029
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2015 - 2020
8.2.4.5.5.2. Market
Forecast, 2021 - 2029
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offering
9. Global Diagnostic Electrocardiograph (ECG) Market Analysis
and Forecasts, 2021 – 2029
9.1. Overview
9.2. Global
Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and Forecasts, By
Lead Type
9.2.1. 12 Lead
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2020
9.2.1.3. Market Forecast, 2021 - 2029
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2020
9.2.1.5.1.2. Market
Forecast, 2021 - 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2020
9.2.1.5.2.2. Market
Forecast, 2021 - 2029
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2020
9.2.1.5.3.2. Market
Forecast, 2021 - 2029
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2020
9.2.1.5.4.2. Market
Forecast, 2021 - 2029
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2020
9.2.1.5.5.2. Market
Forecast, 2021 - 2029
9.2.2. 5 Lead
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2020
9.2.2.3. Market Forecast, 2021 - 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2020
9.2.2.5.1.2. Market
Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2020
9.2.2.5.2.2. Market
Forecast, 2021 - 2029
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2020
9.2.2.5.3.2. Market
Forecast, 2021 - 2029
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2020
9.2.2.5.4.2. Market
Forecast, 2021 - 2029
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2020
9.2.2.5.5.2. Market
Forecast, 2021 - 2029
9.2.3. 3 Lead
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2020
9.2.3.3. Market Forecast, 2021 - 2029
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2020
9.2.3.5.1.2. Market
Forecast, 2021 - 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2020
9.2.3.5.2.2. Market
Forecast, 2021 - 2029
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2020
9.2.3.5.3.2. Market
Forecast, 2021 - 2029
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2020
9.2.3.5.4.2. Market
Forecast, 2021 - 2029
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2020
9.2.3.5.5.2. Market
Forecast, 2021 - 2029
9.2.4. 6 Lead
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2020
9.2.4.3. Market Forecast, 2021 - 2029
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2020
9.2.4.5.1.2. Market
Forecast, 2021 - 2029
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2020
9.2.4.5.2.2. Market
Forecast, 2021 - 2029
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2020
9.2.4.5.3.2. Market
Forecast, 2021 - 2029
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2020
9.2.4.5.4.2. Market
Forecast, 2021 - 2029
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2020
9.2.4.5.5.2. Market
Forecast, 2021 - 2029
9.2.5. Others
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2020
9.2.5.3. Market Forecast, 2021 - 2029
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2015 - 2020
9.2.5.5.1.2. Market
Forecast, 2021 - 2029
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2020
9.2.5.5.2.2. Market
Forecast, 2021 - 2029
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2020
9.2.5.5.3.2. Market
Forecast, 2021 - 2029
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2020
9.2.5.5.4.2. Market
Forecast, 2021 - 2029
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2015 - 2020
9.2.5.5.5.2. Market
Forecast, 2021 - 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By Lead
Type
10. Global Diagnostic Electrocardiograph (ECG) Market Analysis
and Forecasts, 2021 – 2029
10.1. Overview
10.2. Global
Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and Forecasts, By
End Users
10.2.1. Hospitals
and Clinics
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2020
10.2.1.5.1.2. Market
Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2020
10.2.1.5.2.2. Market
Forecast, 2021 - 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2020
10.2.1.5.3.2. Market
Forecast, 2021 - 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2020
10.2.1.5.4.2. Market
Forecast, 2021 - 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2020
10.2.1.5.5.2. Market
Forecast, 2021 - 2029
10.2.2. Ambulatory
Surgical Centers
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2020
10.2.2.5.1.2. Market
Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2020
10.2.2.5.2.2. Market
Forecast, 2021 - 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2020
10.2.2.5.3.2. Market
Forecast, 2021 - 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2020
10.2.2.5.4.2. Market
Forecast, 2021 - 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2020
10.2.2.5.5.2. Market
Forecast, 2021 - 2029
10.2.3. Cardiac
Centers
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2020
10.2.3.3. Market Forecast, 2021 - 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2020
10.2.3.5.1.2. Market
Forecast, 2021 - 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2020
10.2.3.5.2.2. Market
Forecast, 2021 - 2029
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2020
10.2.3.5.3.2. Market
Forecast, 2021 - 2029
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2020
10.2.3.5.4.2. Market
Forecast, 2021 - 2029
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2020
10.2.3.5.5.2. Market
Forecast, 2021 - 2029
10.2.4. Others
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2020
10.2.4.3. Market Forecast, 2021 - 2029
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2020
10.2.4.5.1.2. Market
Forecast, 2021 - 2029
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2020
10.2.4.5.2.2. Market
Forecast, 2021 - 2029
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2020
10.2.4.5.3.2. Market
Forecast, 2021 - 2029
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2020
10.2.4.5.4.2. Market
Forecast, 2021 - 2029
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2020
10.2.4.5.5.2. Market
Forecast, 2021 - 2029
10.3. Key
Segment for Channeling Investments
10.3.1. By End
Users
11. North America Diagnostic Electrocardiograph (ECG) Market
Analysis and Forecasts, 2021 - 2029
11.1. Overview
11.1.1. North
America Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn)
11.2. North
America Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By Offering
11.2.1. Systems
11.2.1.1. Holter ECG
11.2.1.2. Stress/ Exercise Testing ECG
11.2.1.3. Resting ECG
11.2.1.4. Insertable Cardiac Monitor (ICM)
11.2.1.5. Mobile Cardiac Telemetry (MCT)
11.2.1.6. Event Recorder
11.2.1.7. Others
11.2.2. Parts
and Accessories
11.2.3. Software
11.2.4. Services
11.3. North
America Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By Lead Type
11.3.1. 12 Lead
11.3.2. 5 Lead
11.3.3. 3 Lead
11.3.4. 6 Lead
11.3.5. Others
11.4. North
America Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By End Users
11.4.1. Hospitals
and Clinics
11.4.2. Ambulatory
Surgical Centers
11.4.3. Cardiac
Centers
11.4.4. Others
11.5. North
America Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and Forecasts,
By Country
11.5.1. U.S
11.5.1.1. U.S Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
11.5.1.1.1. Systems
11.5.1.1.1.1. Holter
ECG
11.5.1.1.1.2. Stress/
Exercise Testing ECG
11.5.1.1.1.3. Resting
ECG
11.5.1.1.1.4. Insertable
Cardiac Monitor (ICM)
11.5.1.1.1.5. Mobile
Cardiac Telemetry (MCT)
11.5.1.1.1.6. Event
Recorder
11.5.1.1.1.7. Others
11.5.1.1.2. Parts and Accessories
11.5.1.1.3. Software
11.5.1.1.4. Services
11.5.1.2. U.S Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
11.5.1.2.1. 12 Lead
11.5.1.2.2. 5 Lead
11.5.1.2.3. 3 Lead
11.5.1.2.4. 6 Lead
11.5.1.2.5. Others
11.5.1.3. U.S Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
11.5.1.3.1. Hospitals and Clinics
11.5.1.3.2. Ambulatory Surgical Centers
11.5.1.3.3. Cardiac Centers
11.5.1.3.4. Others
11.5.2. Canada
11.5.2.1. Canada Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
11.5.2.1.1. Systems
11.5.2.1.1.1. Holter
ECG
11.5.2.1.1.2. Stress/
Exercise Testing ECG
11.5.2.1.1.3. Resting
ECG
11.5.2.1.1.4. Insertable
Cardiac Monitor (ICM)
11.5.2.1.1.5. Mobile
Cardiac Telemetry (MCT)
11.5.2.1.1.6. Event
Recorder
11.5.2.1.1.7. Others
11.5.2.1.2. Parts and Accessories
11.5.2.1.3. Software
11.5.2.1.4. Services
11.5.2.2. Canada Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
11.5.2.2.1. 12 Lead
11.5.2.2.2. 5 Lead
11.5.2.2.3. 3 Lead
11.5.2.2.4. 6 Lead
11.5.2.2.5. Others
11.5.2.3. Canada Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
11.5.2.3.1. Hospitals and Clinics
11.5.2.3.2. Ambulatory Surgical Centers
11.5.2.3.3. Cardiac Centers
11.5.2.3.4. Others
11.5.3. Mexico
11.5.3.1. Mexico Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
11.5.3.1.1. Systems
11.5.3.1.1.1. Holter
ECG
11.5.3.1.1.2. Stress/
Exercise Testing ECG
11.5.3.1.1.3. Resting
ECG
11.5.3.1.1.4. Insertable
Cardiac Monitor (ICM)
11.5.3.1.1.5. Mobile
Cardiac Telemetry (MCT)
11.5.3.1.1.6. Event
Recorder
11.5.3.1.1.7. Others
11.5.3.1.2. Parts and Accessories
11.5.3.1.3. Software
11.5.3.1.4. Services
11.5.3.2. Mexico Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
11.5.3.2.1. 12 Lead
11.5.3.2.2. 5 Lead
11.5.3.2.3. 3 Lead
11.5.3.2.4. 6 Lead
11.5.3.2.5. Others
11.5.3.3. Mexico Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
11.5.3.3.1. Hospitals and Clinics
11.5.3.3.2. Ambulatory Surgical Centers
11.5.3.3.3. Cardiac Centers
11.5.3.3.4. Others
11.5.4. Rest of
North America
11.5.4.1. Rest of North America Diagnostic Electrocardiograph (ECG)
Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.4.1.1. Systems
11.5.4.1.1.1. Holter
ECG
11.5.4.1.1.2. Stress/
Exercise Testing ECG
11.5.4.1.1.3. Resting
ECG
11.5.4.1.1.4. Insertable
Cardiac Monitor (ICM)
11.5.4.1.1.5. Mobile
Cardiac Telemetry (MCT)
11.5.4.1.1.6. Event
Recorder
11.5.4.1.1.7. Others
11.5.4.1.2. Parts and Accessories
11.5.4.1.3. Software
11.5.4.1.4. Services
11.5.4.2. Rest of North America Diagnostic Electrocardiograph (ECG)
Market Revenue (US$ Mn) and Forecasts, By Lead Type
11.5.4.2.1. 12 Lead
11.5.4.2.2. 5 Lead
11.5.4.2.3. 3 Lead
11.5.4.2.4. 6 Lead
11.5.4.2.5. Others
11.5.4.3. Rest of North America Diagnostic Electrocardiograph (ECG)
Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.4.3.1. Hospitals and Clinics
11.5.4.3.2. Ambulatory Surgical Centers
11.5.4.3.3. Cardiac Centers
11.5.4.3.4. Others
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Offering
11.6.3. By Lead
Type
11.6.4. By End
Users
12. Europe Diagnostic Electrocardiograph (ECG) Market Analysis
and Forecasts, 2021 - 2029
12.1. Overview
12.1.1. Europe
Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn)
12.2. Europe
Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and Forecasts, By
Offering
12.2.1. Systems
12.2.1.1. Holter ECG
12.2.1.2. Stress/ Exercise Testing ECG
12.2.1.3. Resting ECG
12.2.1.4. Insertable Cardiac Monitor (ICM)
12.2.1.5. Mobile Cardiac Telemetry (MCT)
12.2.1.6. Event Recorder
12.2.1.7. Others
12.2.2. Parts
and Accessories
12.2.3. Software
12.2.4. Services
12.3. Europe Diagnostic
Electrocardiograph (ECG) Market Revenue (US$ Mn) and Forecasts, By Lead Type
12.3.1. 12 Lead
12.3.2. 5 Lead
12.3.3. 3 Lead
12.3.4. 6 Lead
12.3.5. Others
12.4. Europe
Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and Forecasts, By
End Users
12.4.1. Hospitals
and Clinics
12.4.2. Ambulatory
Surgical Centers
12.4.3. Cardiac
Centers
12.4.4. Others
12.5. Europe
Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and Forecasts, By
Country
12.5.1. France
12.5.1.1. France Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
12.5.1.1.1. Systems
12.5.1.1.1.1. Holter
ECG
12.5.1.1.1.2. Stress/
Exercise Testing ECG
12.5.1.1.1.3. Resting
ECG
12.5.1.1.1.4. Insertable
Cardiac Monitor (ICM)
12.5.1.1.1.5. Mobile
Cardiac Telemetry (MCT)
12.5.1.1.1.6. Event
Recorder
12.5.1.1.1.7. Others
12.5.1.1.2. Parts and Accessories
12.5.1.1.3. Software
12.5.1.1.4. Services
12.5.1.2. France Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
12.5.1.2.1. 12 Lead
12.5.1.2.2. 5 Lead
12.5.1.2.3. 3 Lead
12.5.1.2.4. 6 Lead
12.5.1.2.5. Others
12.5.1.3. France Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
12.5.1.3.1. Hospitals and Clinics
12.5.1.3.2. Ambulatory Surgical Centers
12.5.1.3.3. Cardiac Centers
12.5.1.3.4. Others
12.5.2. The UK
12.5.2.1. The UK Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
12.5.2.1.1. Systems
12.5.2.1.1.1. Holter
ECG
12.5.2.1.1.2. Stress/
Exercise Testing ECG
12.5.2.1.1.3. Resting
ECG
12.5.2.1.1.4. Insertable
Cardiac Monitor (ICM)
12.5.2.1.1.5. Mobile
Cardiac Telemetry (MCT)
12.5.2.1.1.6. Event
Recorder
12.5.2.1.1.7. Others
12.5.2.1.2. Parts and Accessories
12.5.2.1.3. Software
12.5.2.1.4. Services
12.5.2.2. The UK Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
12.5.2.2.1. 12 Lead
12.5.2.2.2. 5 Lead
12.5.2.2.3. 3 Lead
12.5.2.2.4. 6 Lead
12.5.2.2.5. Others
12.5.2.3. The UK Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
12.5.2.3.1. Hospitals and Clinics
12.5.2.3.2. Ambulatory Surgical Centers
12.5.2.3.3. Cardiac Centers
12.5.2.3.4. Others
12.5.3. Spain
12.5.3.1. Spain Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
12.5.3.1.1. Systems
12.5.3.1.1.1. Holter
ECG
12.5.3.1.1.2. Stress/
Exercise Testing ECG
12.5.3.1.1.3. Resting
ECG
12.5.3.1.1.4. Insertable
Cardiac Monitor (ICM)
12.5.3.1.1.5. Mobile
Cardiac Telemetry (MCT)
12.5.3.1.1.6. Event
Recorder
12.5.3.1.1.7. Others
12.5.3.1.2. Parts and Accessories
12.5.3.1.3. Software
12.5.3.1.4. Services
12.5.3.2. Spain Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
12.5.3.2.1. 12 Lead
12.5.3.2.2. 5 Lead
12.5.3.2.3. 3 Lead
12.5.3.2.4. 6 Lead
12.5.3.2.5. Others
12.5.3.3. Spain Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
12.5.3.3.1. Hospitals and Clinics
12.5.3.3.2. Ambulatory Surgical Centers
12.5.3.3.3. Cardiac Centers
12.5.3.3.4. Others
12.5.4. Germany
12.5.4.1. Germany Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By Offering
12.5.4.1.1. Systems
12.5.4.1.1.1. Holter
ECG
12.5.4.1.1.2. Stress/
Exercise Testing ECG
12.5.4.1.1.3. Resting
ECG
12.5.4.1.1.4. Insertable
Cardiac Monitor (ICM)
12.5.4.1.1.5. Mobile
Cardiac Telemetry (MCT)
12.5.4.1.1.6. Event
Recorder
12.5.4.1.1.7. Others
12.5.4.1.2. Parts and Accessories
12.5.4.1.3. Software
12.5.4.1.4. Services
12.5.4.2. Germany Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By Lead Type
12.5.4.2.1. 12 Lead
12.5.4.2.2. 5 Lead
12.5.4.2.3. 3 Lead
12.5.4.2.4. 6 Lead
12.5.4.2.5. Others
12.5.4.3. Germany Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By End Users
12.5.4.3.1. Hospitals and Clinics
12.5.4.3.2. Ambulatory Surgical Centers
12.5.4.3.3. Cardiac Centers
12.5.4.3.4. Others
12.5.5. Italy
12.5.5.1. Italy Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
12.5.5.1.1. Systems
12.5.5.1.1.1. Holter
ECG
12.5.5.1.1.2. Stress/
Exercise Testing ECG
12.5.5.1.1.3. Resting
ECG
12.5.5.1.1.4. Insertable
Cardiac Monitor (ICM)
12.5.5.1.1.5. Mobile
Cardiac Telemetry (MCT)
12.5.5.1.1.6. Event
Recorder
12.5.5.1.1.7. Others
12.5.5.1.2. Parts and Accessories
12.5.5.1.3. Software
12.5.5.1.4. Services
12.5.5.2. Italy Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
12.5.5.2.1. 12 Lead
12.5.5.2.2. 5 Lead
12.5.5.2.3. 3 Lead
12.5.5.2.4. 6 Lead
12.5.5.2.5. Others
12.5.5.3. Italy Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
12.5.5.3.1. Hospitals and Clinics
12.5.5.3.2. Ambulatory Surgical Centers
12.5.5.3.3. Cardiac Centers
12.5.5.3.4. Others
12.5.6. Nordic
Countries
12.5.6.1. Nordic Countries Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Offering
12.5.6.1.1. Systems
12.5.6.1.1.1. Holter
ECG
12.5.6.1.1.2. Stress/
Exercise Testing ECG
12.5.6.1.1.3. Resting
ECG
12.5.6.1.1.4. Insertable
Cardiac Monitor (ICM)
12.5.6.1.1.5. Mobile
Cardiac Telemetry (MCT)
12.5.6.1.1.6. Event
Recorder
12.5.6.1.1.7. Others
12.5.6.1.2. Parts and Accessories
12.5.6.1.3. Software
12.5.6.1.4. Services
12.5.6.2. Nordic Countries Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Lead Type
12.5.6.2.1. 12 Lead
12.5.6.2.2. 5 Lead
12.5.6.2.3. 3 Lead
12.5.6.2.4. 6 Lead
12.5.6.2.5. Others
12.5.6.3. Nordic Countries Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By End Users
12.5.6.3.1. Hospitals and Clinics
12.5.6.3.2. Ambulatory Surgical Centers
12.5.6.3.3. Cardiac Centers
12.5.6.3.4. Others
12.5.6.4. Nordic Countries Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux Union Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Offering
12.5.7.1.1. Systems
12.5.7.1.1.1. Holter
ECG
12.5.7.1.1.2. Stress/
Exercise Testing ECG
12.5.7.1.1.3. Resting
ECG
12.5.7.1.1.4. Insertable
Cardiac Monitor (ICM)
12.5.7.1.1.5. Mobile
Cardiac Telemetry (MCT)
12.5.7.1.1.6. Event
Recorder
12.5.7.1.1.7. Others
12.5.7.1.2. Parts and Accessories
12.5.7.1.3. Software
12.5.7.1.4. Services
12.5.7.2. Benelux Union Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Lead Type
12.5.7.2.1. 12 Lead
12.5.7.2.2. 5 Lead
12.5.7.2.3. 3 Lead
12.5.7.2.4. 6 Lead
12.5.7.2.5. Others
12.5.7.3. Benelux Union Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By End Users
12.5.7.3.1. Hospitals and Clinics
12.5.7.3.2. Ambulatory Surgical Centers
12.5.7.3.3. Cardiac Centers
12.5.7.3.4. Others
12.5.7.4. Benelux Union Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest of Europe Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Offering
12.5.8.1.1. Systems
12.5.8.1.1.1. Holter
ECG
12.5.8.1.1.2. Stress/
Exercise Testing ECG
12.5.8.1.1.3. Resting
ECG
12.5.8.1.1.4. Insertable
Cardiac Monitor (ICM)
12.5.8.1.1.5. Mobile
Cardiac Telemetry (MCT)
12.5.8.1.1.6. Event
Recorder
12.5.8.1.1.7. Others
12.5.8.1.2. Parts and Accessories
12.5.8.1.3. Software
12.5.8.1.4. Services
12.5.8.2. Rest of Europe Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Lead Type
12.5.8.2.1. 12 Lead
12.5.8.2.2. 5 Lead
12.5.8.2.3. 3 Lead
12.5.8.2.4. 6 Lead
12.5.8.2.5. Others
12.5.8.3. Rest of Europe Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By End Users
12.5.8.3.1. Hospitals and Clinics
12.5.8.3.2. Ambulatory Surgical Centers
12.5.8.3.3. Cardiac Centers
12.5.8.3.4. Others
12.6. Key Segment
for Channeling Investments
12.6.1. By
Country
12.6.2. By
Offering
12.6.3. By Lead
Type
12.6.4. By End
Users
13. Asia Pacific Diagnostic Electrocardiograph (ECG) Market
Analysis and Forecasts, 2021 - 2029
13.1. Overview
13.1.1. Asia
Pacific Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn)
13.2. Asia
Pacific Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By Offering
13.2.1. Systems
13.2.1.1. Holter ECG
13.2.1.2. Stress/ Exercise Testing ECG
13.2.1.3. Resting ECG
13.2.1.4. Insertable Cardiac Monitor (ICM)
13.2.1.5. Mobile Cardiac Telemetry (MCT)
13.2.1.6. Event Recorder
13.2.1.7. Others
13.2.2. Parts
and Accessories
13.2.3. Software
13.2.4. Services
13.3. Asia
Pacific Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By Lead Type
13.3.1. 12 Lead
13.3.2. 5 Lead
13.3.3. 3 Lead
13.3.4. 6 Lead
13.3.5. Others
13.4. Asia
Pacific Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By End Users
13.4.1. Hospitals
and Clinics
13.4.2. Ambulatory
Surgical Centers
13.4.3. Cardiac
Centers
13.4.4. Others
13.5. Asia
Pacific Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and Forecasts,
By Country
13.5.1. China
13.5.1.1. China Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
13.5.1.1.1. Systems
13.5.1.1.1.1. Holter
ECG
13.5.1.1.1.2. Stress/
Exercise Testing ECG
13.5.1.1.1.3. Resting
ECG
13.5.1.1.1.4. Insertable
Cardiac Monitor (ICM)
13.5.1.1.1.5. Mobile
Cardiac Telemetry (MCT)
13.5.1.1.1.6. Event
Recorder
13.5.1.1.1.7. Others
13.5.1.1.2. Parts and Accessories
13.5.1.1.3. Software
13.5.1.1.4. Services
13.5.1.2. China Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
13.5.1.2.1. 12 Lead
13.5.1.2.2. 5 Lead
13.5.1.2.3. 3 Lead
13.5.1.2.4. 6 Lead
13.5.1.2.5. Others
13.5.1.3. China Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
13.5.1.3.1. Hospitals and Clinics
13.5.1.3.2. Ambulatory Surgical Centers
13.5.1.3.3. Cardiac Centers
13.5.1.3.4. Others
13.5.2. Japan
13.5.2.1. Japan Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
13.5.2.1.1. Systems
13.5.2.1.1.1. Holter
ECG
13.5.2.1.1.2. Stress/
Exercise Testing ECG
13.5.2.1.1.3. Resting
ECG
13.5.2.1.1.4. Insertable
Cardiac Monitor (ICM)
13.5.2.1.1.5. Mobile
Cardiac Telemetry (MCT)
13.5.2.1.1.6. Event
Recorder
13.5.2.1.1.7. Others
13.5.2.1.2. Parts and Accessories
13.5.2.1.3. Software
13.5.2.1.4. Services
13.5.2.2. Japan Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
13.5.2.2.1. 12 Lead
13.5.2.2.2. 5 Lead
13.5.2.2.3. 3 Lead
13.5.2.2.4. 6 Lead
13.5.2.2.5. Others
13.5.2.3. Japan Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
13.5.2.3.1. Hospitals and Clinics
13.5.2.3.2. Ambulatory Surgical Centers
13.5.2.3.3. Cardiac Centers
13.5.2.3.4. Others
13.5.3. India
13.5.3.1. India Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
13.5.3.1.1. Systems
13.5.3.1.1.1. Holter
ECG
13.5.3.1.1.2. Stress/
Exercise Testing ECG
13.5.3.1.1.3. Resting
ECG
13.5.3.1.1.4. Insertable
Cardiac Monitor (ICM)
13.5.3.1.1.5. Mobile
Cardiac Telemetry (MCT)
13.5.3.1.1.6. Event
Recorder
13.5.3.1.1.7. Others
13.5.3.1.2. Parts and Accessories
13.5.3.1.3. Software
13.5.3.1.4. Services
13.5.3.2. India Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
13.5.3.2.1. 12 Lead
13.5.3.2.2. 5 Lead
13.5.3.2.3. 3 Lead
13.5.3.2.4. 6 Lead
13.5.3.2.5. Others
13.5.3.3. India Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
13.5.3.3.1. Hospitals and Clinics
13.5.3.3.2. Ambulatory Surgical Centers
13.5.3.3.3. Cardiac Centers
13.5.3.3.4. Others
13.5.4. New
Zealand
13.5.4.1. New Zealand Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By Offering
13.5.4.1.1. Systems
13.5.4.1.1.1. Holter
ECG
13.5.4.1.1.2. Stress/
Exercise Testing ECG
13.5.4.1.1.3. Resting
ECG
13.5.4.1.1.4. Insertable
Cardiac Monitor (ICM)
13.5.4.1.1.5. Mobile
Cardiac Telemetry (MCT)
13.5.4.1.1.6. Event
Recorder
13.5.4.1.1.7. Others
13.5.4.1.2. Parts and Accessories
13.5.4.1.3. Software
13.5.4.1.4. Services
13.5.4.2. New Zealand Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By Lead Type
13.5.4.2.1. 12 Lead
13.5.4.2.2. 5 Lead
13.5.4.2.3. 3 Lead
13.5.4.2.4. 6 Lead
13.5.4.2.5. Others
13.5.4.3. New Zealand Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By End Users
13.5.4.3.1. Hospitals and Clinics
13.5.4.3.2. Ambulatory Surgical Centers
13.5.4.3.3. Cardiac Centers
13.5.4.3.4. Others
13.5.5. Australia
13.5.5.1. Australia Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By Offering
13.5.5.1.1. Systems
13.5.5.1.1.1. Holter
ECG
13.5.5.1.1.2. Stress/
Exercise Testing ECG
13.5.5.1.1.3. Resting
ECG
13.5.5.1.1.4. Insertable
Cardiac Monitor (ICM)
13.5.5.1.1.5. Mobile
Cardiac Telemetry (MCT)
13.5.5.1.1.6. Event
Recorder
13.5.5.1.1.7. Others
13.5.5.1.2. Parts and Accessories
13.5.5.1.3. Software
13.5.5.1.4. Services
13.5.5.2. Australia Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By Lead Type
13.5.5.2.1. 12 Lead
13.5.5.2.2. 5 Lead
13.5.5.2.3. 3 Lead
13.5.5.2.4. 6 Lead
13.5.5.2.5. Others
13.5.5.3. Australia Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By End Users
13.5.5.3.1. Hospitals and Clinics
13.5.5.3.2. Ambulatory Surgical Centers
13.5.5.3.3. Cardiac Centers
13.5.5.3.4. Others
13.5.6. South
Korea
13.5.6.1. South Korea Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By Offering
13.5.6.1.1. Systems
13.5.6.1.1.1. Holter
ECG
13.5.6.1.1.2. Stress/
Exercise Testing ECG
13.5.6.1.1.3. Resting
ECG
13.5.6.1.1.4. Insertable
Cardiac Monitor (ICM)
13.5.6.1.1.5. Mobile
Cardiac Telemetry (MCT)
13.5.6.1.1.6. Event
Recorder
13.5.6.1.1.7. Others
13.5.6.1.2. Parts and Accessories
13.5.6.1.3. Software
13.5.6.1.4. Services
13.5.6.2. South Korea Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By Lead Type
13.5.6.2.1. 12 Lead
13.5.6.2.2. 5 Lead
13.5.6.2.3. 3 Lead
13.5.6.2.4. 6 Lead
13.5.6.2.5. Others
13.5.6.3. South Korea Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By End Users
13.5.6.3.1. Hospitals and Clinics
13.5.6.3.2. Ambulatory Surgical Centers
13.5.6.3.3. Cardiac Centers
13.5.6.3.4. Others
13.5.7. Southeast
Asia
13.5.7.1. Southeast Asia Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Offering
13.5.7.1.1. Systems
13.5.7.1.1.1. Holter
ECG
13.5.7.1.1.2. Stress/
Exercise Testing ECG
13.5.7.1.1.3. Resting
ECG
13.5.7.1.1.4. Insertable
Cardiac Monitor (ICM)
13.5.7.1.1.5. Mobile
Cardiac Telemetry (MCT)
13.5.7.1.1.6. Event
Recorder
13.5.7.1.1.7. Others
13.5.7.1.2. Parts and Accessories
13.5.7.1.3. Software
13.5.7.1.4. Services
13.5.7.2. Southeast Asia Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Lead Type
13.5.7.2.1. 12 Lead
13.5.7.2.2. 5 Lead
13.5.7.2.3. 3 Lead
13.5.7.2.4. 6 Lead
13.5.7.2.5. Others
13.5.7.3. Southeast Asia Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By End Users
13.5.7.3.1. Hospitals and Clinics
13.5.7.3.2. Ambulatory Surgical Centers
13.5.7.3.3. Cardiac Centers
13.5.7.3.4. Others
13.5.7.4. Southeast Asia Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest of Asia Pacific Diagnostic Electrocardiograph (ECG)
Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.8.1.1. Systems
13.5.8.1.1.1. Holter
ECG
13.5.8.1.1.2. Stress/
Exercise Testing ECG
13.5.8.1.1.3. Resting
ECG
13.5.8.1.1.4. Insertable
Cardiac Monitor (ICM)
13.5.8.1.1.5. Mobile
Cardiac Telemetry (MCT)
13.5.8.1.1.6. Event
Recorder
13.5.8.1.1.7. Others
13.5.8.1.2. Parts and Accessories
13.5.8.1.3. Software
13.5.8.1.4. Services
13.5.8.2. Rest of Asia Pacific Diagnostic Electrocardiograph (ECG)
Market Revenue (US$ Mn) and Forecasts, By Lead Type
13.5.8.2.1. 12 Lead
13.5.8.2.2. 5 Lead
13.5.8.2.3. 3 Lead
13.5.8.2.4. 6 Lead
13.5.8.2.5. Others
13.5.8.3. Rest of Asia Pacific Diagnostic Electrocardiograph (ECG)
Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.8.3.1. Hospitals and Clinics
13.5.8.3.2. Ambulatory Surgical Centers
13.5.8.3.3. Cardiac Centers
13.5.8.3.4. Others
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Offering
13.6.3. By Lead
Type
13.6.4. By End
Users
14. Middle East and Africa Diagnostic Electrocardiograph (ECG)
Market Analysis and Forecasts, 2021 - 2029
14.1. Overview
14.1.1. Middle
East and Africa Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn)
14.2. Middle
East and Africa Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By Offering
14.2.1. Systems
14.2.1.1. Holter ECG
14.2.1.2. Stress/ Exercise Testing ECG
14.2.1.3. Resting ECG
14.2.1.4. Insertable Cardiac Monitor (ICM)
14.2.1.5. Mobile Cardiac Telemetry (MCT)
14.2.1.6. Event Recorder
14.2.1.7. Others
14.2.2. Parts
and Accessories
14.2.3. Software
14.2.4. Services
14.3. Middle
East and Africa Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By Lead Type
14.3.1. 12 Lead
14.3.2. 5 Lead
14.3.3. 3 Lead
14.3.4. 6 Lead
14.3.5. Others
14.4. Middle
East and Africa Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By End Users
14.4.1. Hospitals
and Clinics
14.4.2. Ambulatory
Surgical Centers
14.4.3. Cardiac
Centers
14.4.4. Others
14.5. Middle
East and Africa Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi Arabia Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Offering
14.5.1.1.1. Systems
14.5.1.1.1.1. Holter
ECG
14.5.1.1.1.2. Stress/
Exercise Testing ECG
14.5.1.1.1.3. Resting
ECG
14.5.1.1.1.4. Insertable
Cardiac Monitor (ICM)
14.5.1.1.1.5. Mobile
Cardiac Telemetry (MCT)
14.5.1.1.1.6. Event
Recorder
14.5.1.1.1.7. Others
14.5.1.1.2. Parts and Accessories
14.5.1.1.3. Software
14.5.1.1.4. Services
14.5.1.2. Saudi Arabia Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Lead Type
14.5.1.2.1. 12 Lead
14.5.1.2.2. 5 Lead
14.5.1.2.3. 3 Lead
14.5.1.2.4. 6 Lead
14.5.1.2.5. Others
14.5.1.3. Saudi Arabia Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By End Users
14.5.1.3.1. Hospitals and Clinics
14.5.1.3.2. Ambulatory Surgical Centers
14.5.1.3.3. Cardiac Centers
14.5.1.3.4. Others
14.5.2. UAE
14.5.2.1. UAE Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
14.5.2.1.1. Systems
14.5.2.1.1.1. Holter
ECG
14.5.2.1.1.2. Stress/
Exercise Testing ECG
14.5.2.1.1.3. Resting
ECG
14.5.2.1.1.4. Insertable
Cardiac Monitor (ICM)
14.5.2.1.1.5. Mobile
Cardiac Telemetry (MCT)
14.5.2.1.1.6. Event
Recorder
14.5.2.1.1.7. Others
14.5.2.1.2. Parts and Accessories
14.5.2.1.3. Software
14.5.2.1.4. Services
14.5.2.2. UAE Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
14.5.2.2.1. 12 Lead
14.5.2.2.2. 5 Lead
14.5.2.2.3. 3 Lead
14.5.2.2.4. 6 Lead
14.5.2.2.5. Others
14.5.2.3. UAE Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
14.5.2.3.1. Hospitals and Clinics
14.5.2.3.2. Ambulatory Surgical Centers
14.5.2.3.3. Cardiac Centers
14.5.2.3.4. Others
14.5.3. Egypt
14.5.3.1. Egypt Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
14.5.3.1.1. Systems
14.5.3.1.1.1. Holter
ECG
14.5.3.1.1.2. Stress/
Exercise Testing ECG
14.5.3.1.1.3. Resting
ECG
14.5.3.1.1.4. Insertable
Cardiac Monitor (ICM)
14.5.3.1.1.5. Mobile
Cardiac Telemetry (MCT)
14.5.3.1.1.6. Event
Recorder
14.5.3.1.1.7. Others
14.5.3.1.2. Parts and Accessories
14.5.3.1.3. Software
14.5.3.1.4. Services
14.5.3.2. Egypt Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
14.5.3.2.1. 12 Lead
14.5.3.2.2. 5 Lead
14.5.3.2.3. 3 Lead
14.5.3.2.4. 6 Lead
14.5.3.2.5. Others
14.5.3.3. Egypt Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
14.5.3.3.1. Hospitals and Clinics
14.5.3.3.2. Ambulatory Surgical Centers
14.5.3.3.3. Cardiac Centers
14.5.3.3.4. Others
14.5.4. Kuwait
14.5.4.1. Kuwait Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
14.5.4.1.1. Systems
14.5.4.1.1.1. Holter
ECG
14.5.4.1.1.2. Stress/
Exercise Testing ECG
14.5.4.1.1.3. Resting
ECG
14.5.4.1.1.4. Insertable
Cardiac Monitor (ICM)
14.5.4.1.1.5. Mobile
Cardiac Telemetry (MCT)
14.5.4.1.1.6. Event
Recorder
14.5.4.1.1.7. Others
14.5.4.1.2. Parts and Accessories
14.5.4.1.3. Software
14.5.4.1.4. Services
14.5.4.2. Kuwait Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
14.5.4.2.1. 12 Lead
14.5.4.2.2. 5 Lead
14.5.4.2.3. 3 Lead
14.5.4.2.4. 6 Lead
14.5.4.2.5. Others
14.5.4.3. Kuwait Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
14.5.4.3.1. Hospitals and Clinics
14.5.4.3.2. Ambulatory Surgical Centers
14.5.4.3.3. Cardiac Centers
14.5.4.3.4. Others
14.5.5. South
Africa
14.5.5.1. South Africa Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Offering
14.5.5.1.1. Systems
14.5.5.1.1.1. Holter
ECG
14.5.5.1.1.2. Stress/
Exercise Testing ECG
14.5.5.1.1.3. Resting
ECG
14.5.5.1.1.4. Insertable
Cardiac Monitor (ICM)
14.5.5.1.1.5. Mobile
Cardiac Telemetry (MCT)
14.5.5.1.1.6. Event
Recorder
14.5.5.1.1.7. Others
14.5.5.1.2. Parts and Accessories
14.5.5.1.3. Software
14.5.5.1.4. Services
14.5.5.2. South Africa Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By Lead Type
14.5.5.2.1. 12 Lead
14.5.5.2.2. 5 Lead
14.5.5.2.3. 3 Lead
14.5.5.2.4. 6 Lead
14.5.5.2.5. Others
14.5.5.3. South Africa Diagnostic Electrocardiograph (ECG) Market
Revenue (US$ Mn) and Forecasts, By End Users
14.5.5.3.1. Hospitals and Clinics
14.5.5.3.2. Ambulatory Surgical Centers
14.5.5.3.3. Cardiac Centers
14.5.5.3.4. Others
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest of Middle East & Africa Diagnostic Electrocardiograph
(ECG) Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.6.1.1. Systems
14.5.6.1.1.1. Holter
ECG
14.5.6.1.1.2. Stress/
Exercise Testing ECG
14.5.6.1.1.3. Resting
ECG
14.5.6.1.1.4. Insertable
Cardiac Monitor (ICM)
14.5.6.1.1.5. Mobile
Cardiac Telemetry (MCT)
14.5.6.1.1.6. Event
Recorder
14.5.6.1.1.7. Others
14.5.6.1.2. Parts and Accessories
14.5.6.1.3. Software
14.5.6.1.4. Services
14.5.6.2. Rest of Middle East & Africa Diagnostic Electrocardiograph
(ECG) Market Revenue (US$ Mn) and Forecasts, By Lead Type
14.5.6.2.1. 12 Lead
14.5.6.2.2. 5 Lead
14.5.6.2.3. 3 Lead
14.5.6.2.4. 6 Lead
14.5.6.2.5. Others
14.5.6.3. Rest of Middle East & Africa Diagnostic Electrocardiograph
(ECG) Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.6.3.1. Hospitals and Clinics
14.5.6.3.2. Ambulatory Surgical Centers
14.5.6.3.3. Cardiac Centers
14.5.6.3.4. Others
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Offering
14.6.3. By Lead
Type
14.6.4. By End
Users
15. Latin America Diagnostic Electrocardiograph (ECG) Market
Analysis and Forecasts, 2021 - 2029
15.1. Overview
15.1.1. Latin
America Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn)
15.2. Latin
America Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By Offering
15.2.1. Systems
15.2.1.1. Holter ECG
15.2.1.2. Stress/ Exercise Testing ECG
15.2.1.3. Resting ECG
15.2.1.4. Insertable Cardiac Monitor (ICM)
15.2.1.5. Mobile Cardiac Telemetry (MCT)
15.2.1.6. Event Recorder
15.2.1.7. Others
15.2.2. Parts
and Accessories
15.2.3. Software
15.2.4. Services
15.3. Latin
America Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By Lead Type
15.3.1. 12 Lead
15.3.2. 5 Lead
15.3.3. 3 Lead
15.3.4. 6 Lead
15.3.5. Others
15.4. Latin
America Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By End Users
15.4.1. Hospitals
and Clinics
15.4.2. Ambulatory
Surgical Centers
15.4.3. Cardiac
Centers
15.4.4. Others
15.5. Latin
America Diagnostic Electrocardiograph (ECG) Market Revenue (US$ Mn) and
Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Offering
15.5.1.1.1. Systems
15.5.1.1.1.1. Holter
ECG
15.5.1.1.1.2. Stress/
Exercise Testing ECG
15.5.1.1.1.3. Resting
ECG
15.5.1.1.1.4. Insertable
Cardiac Monitor (ICM)
15.5.1.1.1.5. Mobile
Cardiac Telemetry (MCT)
15.5.1.1.1.6. Event
Recorder
15.5.1.1.1.7. Others
15.5.1.1.2. Parts and Accessories
15.5.1.1.3. Software
15.5.1.1.4. Services
15.5.1.2. Brazil Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By Lead Type
15.5.1.2.1. 12 Lead
15.5.1.2.2. 5 Lead
15.5.1.2.3. 3 Lead
15.5.1.2.4. 6 Lead
15.5.1.2.5. Others
15.5.1.3. Brazil Diagnostic Electrocardiograph (ECG) Market Revenue (US$
Mn) and Forecasts, By End Users
15.5.1.3.1. Hospitals and Clinics
15.5.1.3.2. Ambulatory Surgical Centers
15.5.1.3.3. Cardiac Centers
15.5.1.3.4. Others
15.5.2. Argentina
15.5.2.1. Argentina Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By Offering
15.5.2.1.1. Systems
15.5.2.1.1.1. Holter
ECG
15.5.2.1.1.2. Stress/
Exercise Testing ECG
15.5.2.1.1.3. Resting
ECG
15.5.2.1.1.4. Insertable
Cardiac Monitor (ICM)
15.5.2.1.1.5. Mobile
Cardiac Telemetry (MCT)
15.5.2.1.1.6. Event
Recorder
15.5.2.1.1.7. Others
15.5.2.1.2. Parts and Accessories
15.5.2.1.3. Software
15.5.2.1.4. Services
15.5.2.2. Argentina Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By Lead Type
15.5.2.2.1. 12 Lead
15.5.2.2.2. 5 Lead
15.5.2.2.3. 3 Lead
15.5.2.2.4. 6 Lead
15.5.2.2.5. Others
15.5.2.3. Argentina Diagnostic Electrocardiograph (ECG) Market Revenue
(US$ Mn) and Forecasts, By End Users
15.5.2.3.1. Hospitals and Clinics
15.5.2.3.2. Ambulatory Surgical Centers
15.5.2.3.3. Cardiac Centers
15.5.2.3.4. Others
15.5.3. Rest of
Latin America
15.5.3.1. Rest of Latin America Diagnostic Electrocardiograph (ECG)
Market Revenue (US$ Mn) and Forecasts, By Offering
15.5.3.1.1. Systems
15.5.3.1.1.1. Holter
ECG
15.5.3.1.1.2. Stress/
Exercise Testing ECG
15.5.3.1.1.3. Resting
ECG
15.5.3.1.1.4. Insertable
Cardiac Monitor (ICM)
15.5.3.1.1.5. Mobile
Cardiac Telemetry (MCT)
15.5.3.1.1.6. Event
Recorder
15.5.3.1.1.7. Others
15.5.3.1.2. Parts and Accessories
15.5.3.1.3. Software
15.5.3.1.4. Services
15.5.3.2. Rest of Latin America Diagnostic Electrocardiograph (ECG)
Market Revenue (US$ Mn) and Forecasts, By Lead Type
15.5.3.2.1. 12 Lead
15.5.3.2.2. 5 Lead
15.5.3.2.3. 3 Lead
15.5.3.2.4. 6 Lead
15.5.3.2.5. Others
15.5.3.3. Rest of Latin America Diagnostic Electrocardiograph (ECG)
Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.3.3.1. Hospitals and Clinics
15.5.3.3.2. Ambulatory Surgical Centers
15.5.3.3.3. Cardiac Centers
15.5.3.3.4. Others
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Offering
15.6.3. By Lead
Type
15.6.4. By End
Users
16. Competitive Benchmarking
16.1. Market
Share Analysis, 2020
16.2. Global
Presence and Growth Strategies
16.2.1. Mergers
and Acquisitions
16.2.2. Product
Launches
16.2.3. Investments
Trends
16.2.4. R&D
Initiatives
17. Player Profiles
17.1. BPL
Medical Technologies
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT Analysis
17.1.7. Business
Strategies
17.2. EDAN
Instruments, Inc.
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business Strategies
17.3. FUKUDA DENSHI
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business
Strategies
17.4. General Electric Company
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. Hill-Rom Holdings, Inc.
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. Koninklijke Philips N.V.
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. Medtronic
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key
Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. NIHON KOHDEN CORPORATION.
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT Analysis
17.8.7. Business
Strategies
17.9. Norav Medical
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT
Analysis
17.9.7. Business
Strategies
17.10. OSI Systems, Inc.
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key Developments
17.10.5. Financial
Analysis
17.10.6. SWOT
Analysis
17.10.7. Business
Strategies
17.11. SCHILLER
17.11.1.
Company Details
17.11.2.
Company Overview
17.11.3.
Product Offerings
17.11.4.
Key Developments
17.11.5.
Financial Analysis
17.11.6.
SWOT Analysis
17.11.7. Business
Strategies
17.12. Shenzhen Mindray Bio-Medical
Electronics Co., Ltd.
17.12.1.
Company Details
17.12.2.
Company Overview
17.12.3.
Product Offerings
17.12.4.
Key Developments
17.12.5.
Financial Analysis
17.12.6.
SWOT Analysis
17.12.7. Business
Strategies
17.13. Other Market Participants
18. Key Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.